miR-30a Serves as a Tumor Suppressor for Hepatocellular Carcinoma by Downregulating ADAMTS14

Clinical Laboratory
|May 10, 2022
PubMed
Abstract

Insights

MicroRNA-30a (miR-30a) functions as a tumor suppressor in hepatocellular carcinoma (HCC) progression. This microRNA inhibits tumor growth and can serve as a biomarker for early HCC detection.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent malignancy with limited therapeutic advancements for advanced stages.
  • The role of microRNA-30a (miR-30a) in HCC tumorigenesis requires further investigation.

Purpose of the Study:

  • To elucidate the function of miR-30a in hepatocellular carcinoma (HCC) development.
  • To determine the relationship between miR-30a and ADAMTS14 in HCC.

Main Methods:

  • Assessed miR-30a and ADAMTS14 expression in HCC tissues.
  • Utilized luciferase reporter assays to confirm the miR-30a-ADAMTS14 interaction.
  • Evaluated cell viability, apoptosis, migration, and invasion using MTT, flow cytometry, and Transwell assays.
  • Determined protein levels of ADAMTS14, β-catenin, and GSK-3β via Western blotting.

Main Results:

  • miR-30a expression was inversely correlated with ADAMTS14 levels in HCC.
  • ADAMTS14 was identified as a direct target of miR-30a.
  • miR-30a overexpression suppressed ADAMTS14, cell viability, and apoptosis, while promoting apoptosis.
  • miR-30a inhibited GSK-3β and β-catenin phosphorylation, impacting the Wnt/β-catenin pathway.

Conclusions:

  • miR-30a acts as a tumor suppressor in HCC progression.
  • miR-30a demonstrates potential as a biomarker for early prediction and diagnosis of HCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K